Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bruker (BRKR) EBIT (2016 - 2025)

Historic EBIT for Bruker (BRKR) over the last 17 years, with Q3 2025 value amounting to -$51.8 million.

  • Bruker's EBIT fell 17606.46% to -$51.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.0 million, marking a year-over-year decrease of 7750.44%. This contributed to the annual value of $253.1 million for FY2024, which is 4206.91% down from last year.
  • As of Q3 2025, Bruker's EBIT stood at -$51.8 million, which was down 17606.46% from $11.9 million recorded in Q2 2025.
  • Over the past 5 years, Bruker's EBIT peaked at $131.3 million during Q3 2022, and registered a low of -$51.8 million during Q3 2025.
  • In the last 5 years, Bruker's EBIT had a median value of $86.2 million in 2023 and averaged $80.4 million.
  • In the last 5 years, Bruker's EBIT surged by 44329.27% in 2021 and then plummeted by 17606.46% in 2025.
  • Quarter analysis of 5 years shows Bruker's EBIT stood at $125.4 million in 2021, then rose by 4.47% to $131.0 million in 2022, then fell by 20.99% to $103.5 million in 2023, then tumbled by 30.34% to $72.1 million in 2024, then crashed by 171.84% to -$51.8 million in 2025.
  • Its EBIT was -$51.8 million in Q3 2025, compared to $11.9 million in Q2 2025 and $31.8 million in Q1 2025.